Dr. William Lee Senf Ii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 703 Alcorn Dr, Suite 107, Corinth, MS 38834 Phone: 662-284-9888 Fax: 662-284-9899 |
News Archive
Specialty drug discovery company, Innovimmune Biotherapeutics, Inc. has been awarded a $600,000 Advanced Technology Small Business Innovation Research Grant from the National Institutes of Health (NIH).
Ironshore Pharmaceuticals & Development, Inc. has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD).
In a new report, 'The Demography of Medical Schools', the BMA reveals marked differences in medical school acceptance rates between ethnic groups and social classes, and calls for action to ensure that no discrimination is taking place.
Bionovo, Inc. has announced the online publication of a peer-reviewed article in the journal, Menopause, reporting Menerba (formerly MF101) is well tolerated, safe and effective for the treatment of vasomotor symptoms (hot flashes and night sweats) associated with menopause.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
› Verified 7 days ago